How Gut Nerves Release and Process Their Own Opioid Peptides

Gut myenteric plexus neurons release pro-enkephalin fragments at 29-43% of their tissue content when stimulated, revealing the processing and release patterns of the gut's own opioid system.

Corbett, A D et al.·Journal of receptor research·1991·Preliminary EvidenceAnimal StudyAnimal Study
RPEP-00189Animal StudyPreliminary Evidence1991RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Pro-enkephalin fragments were released at 29-43% of tissue content loss. BAM-8 released at higher rates. The precursor BAM-18 was not released.

Key Numbers

How They Did This

Guinea pig myenteric plexus-longitudinal muscle preparations were electrically stimulated in vitro. Released opioid peptides were measured in the perfusion fluid and correlated with tissue content changes.

Why This Research Matters

This study reveals how gut nerves process and release their own opioid peptides. Understanding this processing could help explain gut pain control and opioid-related gut disorders.

The Bigger Picture

Understanding how the gut processes and releases its own opioid peptides is fundamental to gut physiology and pain management. Abnormal processing could contribute to conditions like irritable bowel syndrome.

What This Study Doesn't Tell Us

In vitro study using isolated guinea pig gut tissue. Electrical stimulation may not perfectly mimic natural nerve activity. Results may not apply to human gut tissue.

Questions This Raises

  • ?Is gut opioid peptide processing altered in functional bowel disorders?
  • ?Could targeting gut opioid processing improve GI symptoms?

Trust & Context

Key Stat:
29-43% of tissue content released Pro-enkephalin fragments released from gut nerves proportionally to tissue content decrease during electrical stimulation
Evidence Grade:
Preliminary in-vitro study using guinea pig gut tissue. Comprehensive peptide measurement but artificial stimulation conditions.
Study Age:
Published in 1991. Enteric opioid peptide processing has been further characterized in the context of gut motility disorders.
Original Title:
Electrically-induced release of opioid peptides from the guinea-pig myenteric plexus preparation.
Published In:
Journal of receptor research, 11(1-4), 665-73 (1991)
Database ID:
RPEP-00189

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

Why does the gut have its own opioid system?

The gut needs precise local control of motility, secretion, and pain signaling. Its own opioid peptide system provides this control without relying on brain-derived signals.

Why is BAM-18 not released?

BAM-18 is a precursor that must be processed (cut) inside the nerve terminal before the active fragments can be released. This shows the gut has quality control — it only releases fully processed, active peptides.

Read More on RethinkPeptides

Cite This Study

RPEP-00189·https://rethinkpeptides.com/research/RPEP-00189

APA

Corbett, A D; Gillan, M G; Kosterlitz, H W. (1991). Electrically-induced release of opioid peptides from the guinea-pig myenteric plexus preparation.. Journal of receptor research, 11(1-4), 665-73.

MLA

Corbett, A D, et al. "Electrically-induced release of opioid peptides from the guinea-pig myenteric plexus preparation.." Journal of receptor research, 1991.

RethinkPeptides

RethinkPeptides Research Database. "Electrically-induced release of opioid peptides from the gui..." RPEP-00189. Retrieved from https://rethinkpeptides.com/research/corbett-1991-electricallyinduced-release-of-opioid

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.